Versant Capital Management’s Medpace MEDP Stock Holding History

Versant Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$160K	Buy	303 +4	+1%	+$1.85K	0.01%	712
2026 Q1	$144K	Buy	299 +2	+0.7%	+$1.02K	0.01%	713
2025 Q4	$167K	Hold	297	–	–	0.02%	560
2025 Q3	$153K	Hold	297	–	–	0.02%	561
2025 Q2	$93.2K	Buy	297 +256	+624%	+$76.9K	0.01%	696
2025 Q1	$12.5K	Buy	41 +38	+1,267%	+$12.8K	﹤0.01%	1607
2024 Q4	$997	Hold	3	–	–	﹤0.01%	2196
2024 Q3	$1K	Hold	3	–	–	﹤0.01%	1743
2024 Q2	$1.24K	Hold	3	–	–	﹤0.01%	1625
2024 Q1	$1.21K	Hold	3	–	–	﹤0.01%	1491
2023 Q4	$920	Hold	3	–	–	﹤0.01%	1537
2023 Q3	$726	Hold	3	–	–	﹤0.01%	1619
2023 Q2	$721	Buy	+3	New	+$623	﹤0.01%	1721
2019 Q4	–	Sell	-9	Closed	–	–	1493
2019 Q3	$0	Buy	+9	New	+$680	﹤0.01%	1501

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Versant Capital Management's MEDP Position: Q2 2026 in Review

Versant Capital Management increased its Medpace (MEDP) stake by 1.3% in Q2 2026, buying an estimated $1.85K and bringing the position to 303 shares worth $160K. The position accounts for 0.01% of the portfolio, ranked #712.

Versant Capital Management first reported a position in MEDP in Q3 2019 and has held it in 14 quarters since. The position peaked at $167K in Q4 2025. 699 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

Versant Capital Management held 303 shares of Medpace worth $160K as of Q2 2026.
Versant Capital Management bought 4 Medpace shares in Q2 2026, an estimated $1.85K.
Medpace made up 0.01% of Versant Capital Management's portfolio in Q2 2026, its #712 holding.
Versant Capital Management first reported a position in Medpace in Q3 2019 and has held it in 14 quarters since.
Versant Capital Management's Medpace position peaked at $167K in Q4 2025.
699 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.